Answers are grounded in this paper and cite their sources.
Preclinical study reveals scalable synthesis of selective salvinorin alkyne probes across over 300 GPCR targets, highlighting their potential for in situ receptor imaging.
The salvinorins represent a unique class of polyoxygenated, non-nitrogenous diterpenes that potently and selectively modulate the kappa-opioid receptor (KOR). We recently disclosed a de novo asymmetric synthesis of this scaffold that enabled the discovery of highly potent, biased analogs, including C11-alkynes designed for the CATCH (Clearing-Assisted Tissue Click Chemistry) assay. Here, we report an optimized, scalable synthetic route that substitutes a problematic 1,4-conjugate addition of a Grignard reagent with a robust organozinc protocol in DMA, and improves a samarium-mediated Reformatsky reaction via the addition of LiBr. These methodological improvements facilitated the scalable synthesis of two highly active positive-control probes and three tailored negative-control probes, including functionally silent and cross-linking deficient analogs. A screen of >300 GPCRs confirmed the exceptional KOR selectivity of the novel alkyne probe, establishing it as a promising tool poised to validate target-specific engagement in situ, an application currently under investigation.
No takes yet. Share an insight, caveat, or question.
Cotter et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: